IL164904A0 - Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-Ä(2-methyl-1H-imidazol-1-YL)methylÜ-4H-carbazol-4-one - Google Patents

Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-Ä(2-methyl-1H-imidazol-1-YL)methylÜ-4H-carbazol-4-one

Info

Publication number
IL164904A0
IL164904A0 IL16490404A IL16490404A IL164904A0 IL 164904 A0 IL164904 A0 IL 164904A0 IL 16490404 A IL16490404 A IL 16490404A IL 16490404 A IL16490404 A IL 16490404A IL 164904 A0 IL164904 A0 IL 164904A0
Authority
IL
Israel
Prior art keywords
methyl
preparing
methylü
carbazol
imidazol
Prior art date
Application number
IL16490404A
Other languages
English (en)
Original Assignee
Biogal Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Pharmaceutical Co Ltd filed Critical Biogal Pharmaceutical Co Ltd
Publication of IL164904A0 publication Critical patent/IL164904A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D521/00—Heterocyclic compounds containing unspecified hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
IL16490404A 2002-04-29 2004-10-28 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-Ä(2-methyl-1H-imidazol-1-YL)methylÜ-4H-carbazol-4-one IL164904A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37632302P 2002-04-29 2002-04-29
PCT/US2003/013221 WO2003093281A1 (en) 2002-04-29 2003-04-29 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one

Publications (1)

Publication Number Publication Date
IL164904A0 true IL164904A0 (en) 2005-12-18

Family

ID=29401332

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16490404A IL164904A0 (en) 2002-04-29 2004-10-28 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-Ä(2-methyl-1H-imidazol-1-YL)methylÜ-4H-carbazol-4-one

Country Status (19)

Country Link
US (2) US7098345B2 (de)
EP (1) EP1499623B1 (de)
JP (1) JP2005529142A (de)
KR (1) KR20040104654A (de)
CN (1) CN1665823A (de)
AT (1) ATE364611T1 (de)
AU (1) AU2003223764A1 (de)
CA (1) CA2483566A1 (de)
DE (1) DE60314400T2 (de)
DK (1) DK1499623T3 (de)
ES (1) ES2288606T3 (de)
HR (1) HRP20041070A2 (de)
IL (1) IL164904A0 (de)
MX (1) MXPA04010846A (de)
NO (1) NO20045192L (de)
PL (1) PL373191A1 (de)
PT (1) PT1499623E (de)
WO (1) WO2003093281A1 (de)
ZA (1) ZA200408934B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL366150A1 (en) * 2000-10-30 2005-01-24 Teva Pharmaceutical Industries Ltd. Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
CN1665803A (zh) * 2002-04-30 2005-09-07 特瓦药厂有限公司 新晶形的昂丹司琼及其制备方法、含有该新晶形的药物组合物以及用其治疗恶心的方法
US7696356B2 (en) * 2004-08-17 2010-04-13 Taro Pharmaceutical Industries Limited Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one and ondansetron therefrom
EP1828141A4 (de) * 2004-10-26 2009-04-01 Ipca Lab Ltd Eintopfverfahren zur herstellung des antiemetikums 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl)-1h-imidazol-1-yl)methyl]-4h-carbazol-4-on

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR920003064B1 (ko) 1984-01-25 1992-04-13 글락소 그룹 리미티드 헤테로시클릭 화합물의 제조방법
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
EP0405617A3 (en) * 1985-03-14 1992-11-25 Beecham Group P.L.C. Medicaments for the treatment of anxiety
GB8518741D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8518745D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518742D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
US4859662A (en) * 1986-11-28 1989-08-22 Glaxo Group Limited Tetrahydro-imidazolylmethylcarbazolones and analogs thereof for treating 5-HT function disturbances
GB8630071D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
GB8816187D0 (en) * 1988-07-07 1988-08-10 Glaxo Group Ltd Medicaments
GB8914804D0 (en) 1989-06-28 1989-08-16 Glaxo Group Ltd Process
US5344658A (en) * 1989-06-28 1994-09-06 Glaxo Group Limited Process and composition using ondansetron
CA2112487C (en) * 1991-06-26 2003-04-15 James W. Young Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
CA2106642C (en) * 1992-10-14 2005-08-16 Peter Bod Carbazolone derivatives and process for preparing the same
GB9423588D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
GB9423511D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
CN1045437C (zh) 1994-12-29 1999-10-06 中国科学院上海有机化学研究所 恩丹西酮及其生理盐的合成
PL366150A1 (en) 2000-10-30 2005-01-24 Teva Pharmaceutical Industries Ltd. Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
EP1207160A1 (de) * 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Verfahren zur Herstellung von 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
DE02703115T1 (de) 2001-01-11 2004-10-21 Teva Pharmaceutical Industries Ltd. Verbessertes verfahren zur herstellung von reinem ondansetronhydrochlorid-dihydrat
WO2003090730A1 (en) 2002-04-25 2003-11-06 Generics [Uk] Limited Novel crystalline forms of celecoxib and other compounds
CN1665803A (zh) * 2002-04-30 2005-09-07 特瓦药厂有限公司 新晶形的昂丹司琼及其制备方法、含有该新晶形的药物组合物以及用其治疗恶心的方法

Also Published As

Publication number Publication date
DK1499623T3 (da) 2007-10-08
PL373191A1 (en) 2005-08-22
DE60314400T2 (de) 2008-02-07
HRP20041070A2 (en) 2005-02-28
CN1665823A (zh) 2005-09-07
EP1499623A1 (de) 2005-01-26
ZA200408934B (en) 2006-07-26
US7098345B2 (en) 2006-08-29
ATE364611T1 (de) 2007-07-15
ES2288606T3 (es) 2008-01-16
MXPA04010846A (es) 2005-01-25
CA2483566A1 (en) 2003-11-13
KR20040104654A (ko) 2004-12-10
DE60314400D1 (de) 2007-07-26
WO2003093281A1 (en) 2003-11-13
US20060252942A1 (en) 2006-11-09
NO20045192L (no) 2005-01-28
PT1499623E (pt) 2007-08-10
US20050020655A1 (en) 2005-01-27
EP1499623B1 (de) 2007-06-13
AU2003223764A1 (en) 2003-11-17
JP2005529142A (ja) 2005-09-29

Similar Documents

Publication Publication Date Title
AU2003202585A1 (en) Disubstituted thiazolyl carboxanilides and their use as microbicides
MXPA05009068A (es) Dihidro-pteridinonas, metodo para la produccion y uso del mismo en la forma de farmacos.
PL371582A1 (en) Difluoromethyl thiazolyl carboxanilides
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
MXPA03004187A (es) Produccion de acido 6-aminocaproico.
RS70904A (en) Process for preparing indolinone derivatives
IL175253A0 (en) A process for preparing pyrrole derivatives
NO20071629L (no) Fremgangsmate for fremstilling av 2,7-oktadienylderivater
SI1509517T1 (sl) Nova sinteza irbesartana
WO2006052768A3 (en) Process for preparing quinoline compounds and products obtained therefrom
SG144736A1 (en) Synthesis of temozolomide and analogs
UA87710C2 (ru) Способ получения производных [1,4,5]-оксадиазепина
WO2002092564A3 (en) Synthesis of cyclopentadiene derivatives
IL164904A0 (en) Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-Ä(2-methyl-1H-imidazol-1-YL)methylÜ-4H-carbazol-4-one
Verrier et al. Highly diastereoselective addition of alkoxyethynyl aluminium reagents to N-tert-butylsulfinyl aldimines
MXPA03004986A (es) Proceso para preparar polimeros de emulsion con alta pureza.
WO2005068464A3 (en) Process for preparing tadalafil and its intermediates
SG143062A1 (en) Synthesis of temozolomide and analogs
WO2004026267A3 (en) Tri(alkylcarboxylato) gallium (iii) products and pharmaceutical compositions containing them
WO2008021491A3 (en) Method for synthesis of 8-alkoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones
PL1877370T3 (pl) Sposób wytwarzania pochodnych hydrazonu
WO2021076835A8 (en) Methods for the preparation of 5-bromo-2-(3-chloro-pyridin-2-yl)-2h-pyrazole-3-carboxylic acid
IL158933A0 (en) Method for the production of biperiden ii
WO2000064882A3 (en) Enantiomers of mercapto lactones and processes for their synthesis
MX2009013336A (es) Sintesis de 3-aminopirazoles sustituidos.